Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Infusion site reactions
ADR ID BADD_A06526
ADR Hierarchy
08      General disorders and administration site conditions
08.02      Administration site reactions
08.02.05      Infusion site reactions
12      Injury, poisoning and procedural complications
12.07      Administration site reactions
12.07.05      Infusion site reactions
Description Adverse reactions that occur initially at the site of injection or infusion. Milder type is confined to a local allergic flare reaction. A more severe reaction is caused by extravasation of VESICANTS from the blood vessel at the site of injection and can cause damage to the surrounding tissue. In tumor flare reaction symptoms involve well beyond the injection site such as an increase in the tumor size and tumor markers levels, bone pain, and HYPERCALCEMIA. [MeSH]
MedDRA Code 10068753
MeSH ID D000075662
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Injection Site Reaction | Injection Site Reactions | Injection Site Event | Injection Site Events | Injection Site Adverse Event | Infusion Site Reaction | Infusion Site Reactions | Infusion Site Adverse Reaction | Infusion Site Adverse Event
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D01540Natrecor
BADD_D01556Nesiritide
BADD_D01569Nimodipine
BADD_D01593Obiltoxaximab
BADD_D01623Oritavancin
BADD_D01653Paclitaxel
BADD_D01659Palonosetron
BADD_D01661Pamidronate disodium
BADD_D01662Pamidronic acid
BADD_D01789Plerixafor octahydrochloride
BADD_D01864Propofol
BADD_D01918Raxibacumab
BADD_D01923Remifentanil hydrochloride
BADD_D02046Sodium nitroprusside
BADD_D02110Taliglucerase alfa
BADD_D02143Telavancin
BADD_D02268Treprostinil
BADD_D02269Treprostinil sodium
BADD_D02351Vernakalant hydrochloride
BADD_D02362Vinflunine
BADD_D02392Zoledronic acid
The 3th Page    First    Pre   3    Total 3 Pages